Summit X’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Summit X's LLY Position: Q3 2025 in Review
Summit X sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 3,357 shares — an estimated $2.62M sold.
Summit X first reported a position in LLY in Q2 2017 and held it in 12 quarters. The position peaked at $3.33M in Q2 2024. 3,911 funds tracked by Wall St. Rank hold LLY as of Q3 2025.
- Summit X reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
- Summit X sold 3,357 Eli Lilly shares in Q3 2025, an estimated $2.62M.
- Summit X first reported a position in Eli Lilly in Q2 2017 and held it in 12 quarters.
- Summit X's Eli Lilly position peaked at $3.33M in Q2 2024.
- 3,911 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.
Based on Summit X's 13F filing for Q3 2025.